VALIPHARMA
Cronos Therapeutics, Ltd., a biopharmaceutical company, develops therapeutics and diagnostics based on epigenomics for the detection and treatment of cancer. Its GeneICE compounds represent a way of treating diseases by acting to shut down harmful genes and therefore prevent their expression. The company's HyperGenomics platform characterizes disease state by detecting areas on the chromosome where genes are active. Its compound, which is undergoing development, acts to shut down the Bcl-2 gene. Cronos Therapeutics, Ltd. was founded in 2004 and is based in London, the United Kingdom. As of October 3, 2006, Cronos Therapeutics Ltd. is a subsidiary of ValiRX PLC.
VALIPHARMA
Social Links:
Industry:
Biotechnology Health Diagnostics
Founded:
2004-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.valirx.com
Status:
Active
Contact:
+44 (0)203 0084415
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon WordPress Google Analytics Google Universal Analytics Sitelinks Search Box Yoast WordPress SEO Plugin Nginx Yoast Plugins
Similar Organizations
InnaVirVax
InnaVirVax develops therapeutics, diagnostics, prevention aids, and prognostics for HIV, infectious diseases, and cancers.
Precision Biologics
Precision Biologics develops therapeutic and diagnostic products for the early detection and treatment of cancer.
WILEX
WILEX is a biopharmaceutical company developing drugs and diagnostic agents to detect and treat malignant tumors and cancers.
Current Employees Featured
Official Site Inspections
http://www.valirx.com
- Host name: 77.68.91.156
- IP address: 77.68.91.156
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "ValiPharma"
Accelerating Biomedical Innovation | Drug Development | ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid …See details»
ValiPharma - Crunchbase Company Profile & Funding
ValiPharma develops therapeutics and diagnostics based on epigenomics for the detection and treatment of cancer.See details»
ValiRx plc: Personalized Medicine: Vol 5 , No 5 - Get Access
Sep 9, 2008 · ValiBio is developing low-cost, rapid, high-throughput, noninvasive screening tests for the early detection, differential diagnosis and prognosis of cancer using its patented …See details»
ValiRX - Crunchbase Company Profile & Funding
Valirx Plc, an investment holding company, engages in the research and development of oncology therapeutics and diagnostics in the United Kingdom. The company principally offers VAL 101 …See details»
Pipeline - Pre-Clinical Drugs to Clinical Trials | ValiRx PLC
VALX.L - | Stock Price & Latest News | Reuters
Nov 20, 2024 · ValiRx plc is a life science company. The Company is focused on early-stage cancer therapeutics and women's health. The Company provides the scientific, financial and …See details»
ValiRx Company Profile 2024: Stock Performance & Earnings
ValiRx PLC is a UK-based biopharmaceutical company. It mainly engages in developing technologies and products in oncology therapeutics and diagnostics. The area of focus for the …See details»
ValiRx plc - PubMed
ValiBio is developing low-cost, rapid, high-throughput, noninvasive screening tests for the early detection, differential diagnosis and prognosis of cancer using its patented Hypergenomics™ …See details»
ValiRx PLC, VAL:LSE profile - FT.com - Financial Times
ValiRx PLC (VAL:LSE) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
Company Information - Valirx plc (VAL) - Hargreaves Lansdown
ValiRx plc is a life science company. The Company is focused on early-stage cancer therapeutics and women's health. The Company provides the scientific, financial and commercial …See details»
ValiRx Plc | Insights
Partners AbbVie and Roche's Genentech scored an important win for their B-cell lymphoma-2 (BCL-2) inhibitor venetoclax in a Phase II clinical trial that met the study's primary endpoint in …See details»
ValiRx strikes deal with Ambrose Healthcare to license late-stage ...
Dec 5, 2023 · ValiRx Plc, a life science company focusing on cancer therapeutics and women's health, has announced that ValiRx subsidiary, ValiSeek Ltd, has entered into an exclusive …See details»
ValiRx PLC, VAL:LSE summary - FT.com - Financial Times
6 days ago · Latest ValiRx PLC (VAL:LSE) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.See details»
ValiPharma Company Profile 2024: Valuation, Investors ... - PitchBook
Information on acquisition, funding, investors, and executives for ValiPharma. Use the PitchBook Platform to explore the full profile.See details»
ValiRx (AIM:VAL) - Stock Price, News & Analysis - Simply Wall St
Nov 15, 2024 · ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom.See details»
VAL Stock Price Quote - Morningstar
Nov 18, 2024 · ValiRx PLC is a UK-based biopharmaceutical company. It mainly engages in developing technologies and products in oncology therapeutics and diagnostics. The area of …See details»
Valirx eyes partnerships as first VAL201 study hits the mark
Sep 28, 2020 · Shares in UK biotech Valirx were up sharpy this morning after its lead drug VAL201 showed evidence of efficacy in advanced prostate cancer in its first clinical trial.See details»
VAL 301 - ValiRx - AdisInsight - Springer
Jun 18, 2024 · VAL 301 is a small molecule peptide therapeutic being developed by ValiRx for the treatment of endometriosis. VAL 301 is designed to inhibit androgen activation.See details»
ValiRx plc | Personalized Medicine
ValiRx plc is a therapeutics and diagnostics company developing an integrated approach to the diagnosis, treatment and prognosis of cancer through its two subsidiaries; ValiPharma and …See details»